Evidence map›Paper›PMID 30522526›Full record

ArticleBMC pharmacology & toxicology2018

Evaluation of free radical scavenging capacity of methoxy containing-hybrids of thiosemicarbazone-triazole and their influence on glucose transport.

Ademola O Ayeleso, Jitcy S Joseph, Oluwafemi O Oguntibeju, Emmanuel Mukwevho

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Targeting Diabetes with Azole-derived Medicinal Agents.Medicinal chemistry (Shariqah (United Arab Emirates)) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Ademola O AyelesoDepartment of Biochemistry, North-West University, Mmabatho, 2735, South Africa.
Jitcy S JosephDepartment of Life & Consumer Sciences, University of South Africa, Florida Campus, Johannesburg, 1709, South Africa.
Oluwafemi O OguntibejuOxidative Stress Research Centre, Department of Biomedical Sciences, Cape Peninsula University of Technology, Bellville, 7535, South Africa.
Emmanuel MukwevhoDepartment of Biochemistry, North-West University, Mmabatho, 2735, South Africa. emmanuel.mukwevho@nwu.ac.za.
North-West University · ZACape Peninsula University of Technology · ZAUniversity of South Africa · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus is a metabolic disease in which the body is unable to produce insulin or respond to insulin production, consequently leading to abnormal metabolism of carbohydrates, lipids and proteins causing elevation of glucose in the blood. Oxidative stress, an imbalance between the production of free radicals and body antioxidant system has been implicated in the pathogenesis of diabetes. Free radicals attack important macromolecules leading to cell damage. Antioxidants are intimately involved in the prevention of damage caused by free radicals.

methodsThe anti-diabetic effects of hybrid compounds (2a-h) of thiosemicarbazone and triazole containing methoxy groups at C (4) positions were tested against genes involved in glucose metabolism (Glut-4, Mef2a and Nrf-1) using quantitative real time PCR (qPCR). Free radical scavenging capacity (FRAP, TEAC, DPPH and ORAC) of the hybrids was also carried out by using established antioxidant capacity assays.

resultsFrom the results, hybrid compounds 2b and 2h showed more pronounced effects in up-regulating diabetes associated genes which are important in the up-regulation of glucose uptake. All the hybrid compounds also showed free radical scavenging abilities.

conclusionIn conclusion, hybrid compounds (2b and 2h) can be useful as potential drugs for the management of diabetes mellitus.

Indexed as

3T3-L1 CellsAnimalsBiological TransportFree Radical ScavengersGene Expression RegulationGlucoseGlucose Transporter Type 4Hypoglycemic AgentsMEF2 Transcription FactorsMiceNuclear Respiratory Factor 1ThiosemicarbazonesTriazolesFree Radical ScavengersGlucoseGlucose Transporter Type 4Hypoglycemic AgentsMef2a protein, mouseMEF2 Transcription FactorsNrf1 protein, mouseNuclear Respiratory Factor 1Slc2a4 protein, mouseThiosemicarbazonesTriazolesDiabetesFree radicalHybrid compoundThiosemicarbazoneTriazole

Identifiers

PMID30522526
PMCPMC6282370
OpenAlexW2902299114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.